Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Med Decis Making. 2013 Nov 18;34(4):430–442. doi: 10.1177/0272989X13511705

Table 6.

Logistic-regression results for each “most important reason” (Non-standardized coefficients b (Standard Error (SE)) among those respondents using cholesterol-lowering medication (n = 357). Significant predictors are in bold for emphasis.

Very serious muscle damage
B (SE) 		Prefer to avoid medications
B (SE) 		Serious side effects not likely
B (SE) 		Side effects not serious
B (SE) 		Too many side effects
B (SE) 		You don’t want to experience side effect
B (SE)
Constant −1.92 (.24) −2.40 (.28) −1.13 (.20) −.97 (.18) −2.57 (.30) −3.62 (.57)
Numeric Format −.09 (.24) −.64 (.28) .39 (.20) .14 (.18) −.42 (.30) −.64 (.57)
Numeracy .02 (.13) −.10 (.14) .07 (.10) −.11 (.09) −.15 (.15) .47 (.24)
Age .07 (.32) −.38 (.41) .23 (.26) −.46 (.26) .60 (.37) .87 (.65)
Numeric Format * Numeracy −.14 (.13) .14 (.14) .01 (.10) .02 (.09) −.08 (.15) .30 (.24)
Numeric Format * Age −.21 (.32) .39 (.41) −.17 (.26) −.05 (.26) −.19 (.37) .88 (.65)
Numeracy * Age −.24 (.17) −.10 (.20) .07 (.14) .03 (.13) .22 (.19) −.37 (.28)
Numeric Format * Numeracy * Age .13 (.17) −.22 (.20) .12 (.14) .04 (.13) −.19 (.19) −.50 (.28)
Nagelkerke R2=.04, χ2 (df=7) = 7.1, p=.42 Nagelkerke R2=.07, χ2 (df=7) = 9.8, p=.20 Nagelkerke R2=.05, χ2 (df=7) = 12.6, p=.08 Nagelkerke R2=.03, χ2 (df=7) = 6.8, p=.45 Nagelkerke R2=.07, χ2 (df=7) = 11.5, p=.12 Nagelkerke R2=.08, χ2 (df=7) = 10.4, p=.17